Should You Buy Gilead Sciences Stock on the Dip?
Gilead had donated 1.5 million doses of remdesivir to the U.S. government as of June 30. As a result, Gilead's stock has fallen below $70 for the first time since March. Let's take a closer look at whether Gilead is worth buying today.